Wednesday, October 21, 2009

German doctor calls for parliamentary inquiry into "swine flu" jab scandal

http://www.theflucase.com/index.php?option=com_content&view=article&id=1261%3Agerman-doctor-calls-for-parliamentary-inquiry-into-qswine-fluq-jab-scandal&catid=1%3Alatest-news&Itemid=64&lang=en

ORIGINAL ARTICLE HERE:

A German doctor has called for a parliamentary inquiry into the decision by the German government to purchase GlaxoSmithKline's Pandemrix vaccine and the recommendation of the national vaccine advisory board and Robert Koch Institute in favour of the untested "swine flu" jabs.

Dr Angela Spelsberg, head of a tumour center in Aachen and a member of Transparency International, said in an interview in the mainstream newspaper  Die Sueddeutsche Zeitung that key control mechanisms to protect the general public against dangerous vaccines have stopped functioning.

The exposure of people to dangerous vaccines by the government is "a situation that cannot go on," she said.

She noted that many of the people who sit on the national vaccine advisory board, STIKO, have financial links with the pharmaceutical industry; some are involved in clinical trials on vaccines; some are paid for holding talks on vaccines.

In addition, the European Medicines Agency, the EU drug regulator, derives two thirds of its money from pharma companies, and is subordinated to the business directorate and not the public health directorat of the European Commission.

Spelsberg said that the "swine flu" jabs were not adequately tested. The vaccines were based on so-called mock up vaccines which used much lower amounts of antigens than standard vaccines, and it was not clear how these vaccines functioned or for how long.

In addition, the jabs had adjuvants that were not tested.

She said it was a "scandal" that pharma companies had been given immunity.

She said parliamentary control was vital to stop these kind of scandals occuring in the future.

Here is the interview in German:

http://www.sueddeutsche.de/wissen/231/491596/text/


No comments:

Post a Comment